Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Energy & metal in favour today
Thu, 7 Aug 01:30 pm

Indian share markets continued to trade on a weak note in the post-noon trading session. Barring energy and metal, all the sectoral indices are trading in the red with IT and pharma stocks being the biggest losers.

BSE-Sensex is down 96 points and NSE-Nifty is trading 22 points down. BSE Mid Cap is trading 0.5% down and BSE Small Cap index is trading up by 0.4%. The rupee is trading at 61.48 to the US dollar.

Majority of the cement stocks are trading in the red with J K Lakshmi Cement and Heidelberg Cement being the major losers whereas ACC and Ambuja Cement are among the few stocks trading in the green. As per a leading financial daily, Ultratech Cement is contemplating capital spends of Rs 37.9 bn in FY15. Under its capital expenditure plans, the company wants to add 2.9 million tonnes capacity with supporting grinding units and waste heat recovery in its subsidiary Aditya Cement Works in Rajasthan. Additionally, the company will also invest in modernizing its facility at its jetty in Gujarat. The company has earmarked capital investments of Rs 30.5 bn in FY16 and Rs 2 bn in FY17. Ultratech expects its installed capacity to rise from the present 62 million tonnes to 70 million tonnes by early next year. As per the company, its turnover is expected to reach Rs 250 bn in FY15 from Rs 200.7 bn registered in FY14. Ultratech Cement's stock is currently trading up by 1%.

Majority of the domestic pharma stocks are trading negative with J B Chemicals and Indoco Remedies posting maximum losses. As per a leading financial daily, Cadila Healthcare's listed subsidiary Zydus Cadila has received approval from US Food and Drug Administration (USFDA) to market potassium citrate extended-release tablets in the 5mEq, 10mEq and 15mEq strengths. These tablets are used in the prevention of kidney stones. As per IMS data, the estimated sales for potassium citrate ER tablets is $ 131.7 m. Cadila Healthcare presently has 94 approvals and has filed 239 abbreviated new drug applications so far. Cadila Healthcare's stock is trading up by 0.5%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Energy & metal in favour today". Click here!

  

Related Views on News

UltraTech Cement Q4 Results: 45% Fall in Net Profit (Views On News)

May 10, 2021

Key takeaways from Ultra Tech Cement Q4FY21 results.

ULTRATECH CEMENT Announces Quarterly Results (3QFY21); Net Profit Up 122.8% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, ULTRATECH CEMENT has posted a net profit of Rs 16 bn (up 122.8% YoY). Sales on the other hand came in at Rs 123 bn (up 18.4% YoY). Read on for a complete analysis of ULTRATECH CEMENT's quarterly results.

ULTRATECH CEMENT 2019-20 Annual Report Analysis (Annual Result Update)

Aug 7, 2020 | Updated on Aug 7, 2020

Here's an analysis of the annual report of ULTRATECH CEMENT for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of ULTRATECH CEMENT. Also includes updates on the valuation of ULTRATECH CEMENT.

What's Behind ACC's Highest-Ever Revenue in March Quarter? (Company Info)

Apr 20, 2021

Key takeaways from ACC's March quarter (Q1CY21) results.

ULTRATECH CEMENT Announces Quarterly Results (1QFY21); Net Profit Down 34.0% (Quarterly Result Update)

Jul 30, 2020 | Updated on Jul 30, 2020

For the quarter ended June 2020, ULTRATECH CEMENT has posted a net profit of Rs 8 bn (down 34.0% YoY). Sales on the other hand came in at Rs 76 bn (down 25.0% YoY). Read on for a complete analysis of ULTRATECH CEMENT's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS